Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: LimPrOn: Limburg Pre-eclampsia Investigation
Brief Summary: Background:

Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal. Five to eight percent of all pregnant women worldwide will develop PE.

PE is a pregnancy condition which is characterized with a high blood pressure (\>140/90 mm Hg) and the occurrence of proteinuria (\>3g/dl/24h) after 20 weeks of gestation. When untreated, this condition can have severe complications for both mother and child. It's important to monitor women with a high risk for developing PE for an early detection and treatment of this condition.

For this reason, a multicenter study is set up with the following applications:

1. NICCOMO and Maternal Venous Doppler Echography: impedance cardiograph and an echography of the heart and veins.
2. Maltron: bio-electronic impedance analyze
3. Remote monitoring of the high risk patients to become a more intensive follow-up

Number of inclusions: 2000 pregnant women from the prenatal consultations of eight different hospitals:


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: remote monitoring group; Type: EXPERIMENTAL; Interventions: Device: remote monitoring | Intervention Type: DEVICE; Name: remote monitoring; Assigned to Arm(s): remote monitoring group
B: Arm Label: telemonitoring group (TM); Type: EXPERIMENTAL; Interventions: Device: Telemonitoring | Arm Label: Patient self-monitoring group (PSM); Type: ACTIVE_COMPARATOR; Interventions: Device: Telemonitoring | Arm Label: control group (CC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CAPROM - Group 1; Type: EXPERIMENTAL; Interventions: Other: Longitudinal CV profiling during pregnancy and before and after the start/switch of antihypertensive medication | Arm Label: CAPROM - Group 2; Type: EXPERIMENTAL; Interventions: Other: CV profiling before and after the start/switch of antihypertensive medication | Intervention Type: DEVICE; Name: Telemonitoring; Assigned to Arm(s): Patient self-monitoring group (PSM), telemonitoring group (TM) | Intervention Type: OTHER; Name: Longitudinal CV profiling during pregnancy and before and after the start/switch of antihypertensive medication; Assigned to Arm(s): CAPROM - Group 1 | Intervention Type: OTHER; Name: CV profiling before and after the start/switch of antihypertensive medication; Assigned to Arm(s): CAPROM - Group 2
C: Arm Label: Mercury; Type: NO_INTERVENTION; Interventions: Device: Automated blood pressure recording device Omron HEM 705CP | Intervention Type: DEVICE; Name: Automated blood pressure recording device Omron HEM 705CP; Assigned to Arm(s): Mercury
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Self monitoring of blood pressure using Health Gauge Device and monthly monitoring of weight gain | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Self monitoring of blood pressure using Health Gauge Device and monthly monitoring of weight gain; Assigned to Arm(s): Intervention

Answer: A